- Home
- / Respiri
Respiri
Stock Price
$0
2024-05-17
Market Capitalization
$39.2 M
2024-05-17
Revenue
$75 K
FY, 2023
Respiri Summary
Company Summary
- Overview
- Respiri is a healthtech company providing devices and mobile apps for the management of chronic respiratory disorders such as asthma and chronic obstructive pulmonary disease. Its Wheezo platform provides personalized feedback and education based on a user's data and enables sharing of that data with caregivers and healthcare providers.
- Type
- Public
- Status
- Active
- Founded
- 2006
- HQ
- Melbourne, AU | view all locations
- Website
- http://www.respiri.co/
- Cybersecurity rating
Table of Contents
Key People
Marjan Mikel, Chief Executive Officer
Thomas Duthy, Non-Executive Director
LocationsView all
2 locations detected
Melbourne, VIC HQ
Australia
suite 1, level 9/432 St Kilda Rd
Melbourne, VIC
Australia
Level 27/101 Collins St
Respiri Financials
Summary Financials
- Revenue (H1, 2024)
- $147.0K
- Gross profit (H1, 2024)
- $727.0K
- Net income (H1, 2024)
- ($3.2M)
- Cash (H1, 2024)
- $910.0K
- EBIT (H1, 2024)
- ($3.1M)
- Enterprise value
- $38.3M